Apelin ‐13 treatment enhances the stability of atherosclerotic plaques

ConclusionsApelin‐13 treatment for 3 weeks did not alter the lesion size, but it significantly enhanced the stable phenotype of atherosclerotic plaques and improved serum lipid profile. These results indicate that activation of apelin system decreases plaque vulnerability.This article is protected by copyright. All rights reserved.

Source: European Journal of Clinical Investigation - January 1, 2018 Category: General Medicine Authors: Rodrigo Araujo Fraga ‐Silva, Hugo Seeman, Fabrizio Montecucco, Analina Raquel da Silva, Fabienne Burger, Fabiana Pereira Costa‐Fraga, Léa Anguenot, François Mach, Robson Augusto Souza dos Santos, Nikolaos Stergiopulos, Rafaela Fernandes da Silva Tags: Original Paper Source Type: research